Spruce Biosciences, Inc.
Pharmaceutical company · South San Francisco, California, United States · Nasdaq: SPRB
Spruce Biosciences, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker SPRB. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2025.
Spruce Biosciences at a glance
What does Spruce Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $50 million sold (2025).
Frequently asked questions about Spruce Biosciences
Where is Spruce Biosciences headquartered?
Spruce Biosciences, Inc. is headquartered in South San Francisco, California, United States.
What does Spruce Biosciences do?
Spruce Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Spruce Biosciences a public company?
Yes. Spruce Biosciences, Inc. trades on Nasdaq under the ticker SPRB.
When was Spruce Biosciences founded?
The earliest incorporation on record for Spruce Biosciences, Inc. is in 2016, according to public company registers.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
- Alumis Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.